Genesis Orthopedics and Sports Medicine Delivering Elite Level Sports Medicine and Orthopedic Care to the Most Underserved Part of the Community

Genesis Orthopedics and Sports Medicine, (one of the fastest-growing privately held companies in the country is serving one of the most underserved segments in sports medicine and orthopedics) which was recently named to the Inc. 5000 Fastest-Growing Privately Held Companies, is delivering the same quality of service that pro athletes receive to those who can’t afford it through its proprietary care delivery model.

Genesis Orthopedics and Sports Medicine is led by Dr. Hythem Shadid, one of the top names in Sports Medicine and Orthopedics and former Team Physician for U.S. National Soccer Teams.  Dr. Shadid and Genesis serve patients in eight locations across Chicagoland.

Genesis Orthopedics and Sports Medicine has established a new model where all people are valued and treated, regardless of economic status, with ethical pricing, and where surgery is seen as a last resort and not a preferred revenue source.

Reimbursement rates are low for Medicaid and Medicare in Illinois –  only 1 percent of orthopedic practices accept patients who are on Medicaid or Medicare. Conversely, Genesis’ patient base is made up of approximately 75 percent Medicaid and Medicare patients. “With our care delivery model, we’ve managed to do it sustainably, while still organically growing each year with new offices across Chicagoland to serve even more effectively,” said Andrew Shadid, CEO of Genesis Orthopedics & Sports Medicine.

Dr. Hythem Shadid, President and Orthopedic Surgeon at Genesis Orthopedics & Sports Medicine, is a board-certified orthopedic surgeon with the American Board of Orthopedic Surgeons and has been in practice since 1994. He is a distinguished researcher and specializes in advanced knee, hip, and shoulder conditions. He previously served as the team orthopedic physician for the men’s and women’s U.S. national soccer teams.

“Equity in healthcare is extremely important to us, so we’re dedicated to ensuring that our practice is welcoming to everyone, regardless of income, wealth, or insurance status. Everyone is welcome at Genesis, and we’re excited for what the future holds as we press forward into new possibilities for serving those in orthopedic need,” said Dr. Shadid.

Hot this week

Recor Medical Supports European Society of Cardiology’s Hypertension Guidelines

Record Medical notes the new guidelines, "2024 ESC Guidelines for the management of elevated blood pressure and hypertension," have been published online and recommend the consideration of renal denervation (RDN) as a safe and effective treatment option for patients who have uncontrolled resistant hypertension or those that have uncontrolled hypertension with a higher risk of cardiovascular disease, who express a preference to undergo RDN.

ConTIPI Medical Selects EVERSANA to Support U.S. Commercialization of Non-Surgical Medical Device ProVate for Women with Pelvic Organ Prolapse

EVERSANA is a leading provider of global commercial services to the life sciences industry, to support commercialization for the ProVate device in the United States to help women experiencing pelvic organ prolapse.

Boston Scientific Obtains CE Mark for ACURATE Prime Aortic Valve System

The ACURATE Prime aortic valve system is designed with several features to build upon the clinical performance of the ACURATE neo2™ platform including an additional valve size, which expands the treatment range to patients with a larger anatomy.

Noctrix Health Announces New CMS Reimbursement Codes and Payment for Nidra Tonic Motor Activation Therapy for Restless Legs Syndrome

Nidra TOMAC Tonic Motor Activation Therapy, which was authorized for marketing in the United States last year following its designation as a "Breakthrough Device" by the US Food & Drug Administration (FDA), remains the only clinically validated, non-pharmaceutical treatment available for patients with RLS.

Haemonetics Announces Full Market Release for VASCADE MVP® XL Vascular Closure System

Haemonetics notes the VASCADE MVP XL system is now available to U.S. hospitals as the newest addition to Haemonetics' VASCADE® portfolio of vascular closure systems featuring an innovative collapsible disc technology and a proprietary resorbable collagen patch designed to promote rapid hemostasis.